Ozempic is a brand-name prescription medication that contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily used to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. It works by mimicking the effects of natural GLP-1, which helps regulate blood sugar, slows gastric emptying, and can reduce appetite.
Ompic is a mimic of those and Monero and things like that.
""Dr. Michael Snyder mentioned Ozempic as an example of a GLP-1 drug, alongside Mounjaro, that mimics incretins. He discussed how these drugs significantly increase GLP-1 levels and their effectiveness in managing type 2 diabetes, with Dr. Snyder himself being a user of similar GLP-1 agonists."